Entering text into the input field will update the search result below

TransMedics Group, Inc. (TMDX) CEO Waleed Hassanein on Q2 2022 Results - Earnings Call Transcript

Aug. 02, 2022 12:37 AM ETTransMedics Group, Inc. (TMDX) Stock
SA Transcripts profile picture
SA Transcripts

Start Time: 16:30 January 1, 0000 5:16 PM ET

TransMedics Group, Inc. (NASDAQ:TMDX)

Q2 2022 Earnings Conference Call

August 01, 2022, 16:30 PM ET

Company Participants

Waleed Hassanein - President and CEO

Stephen Gordon - CFO

Brian Johnston - Gilmartin Group

Conference Call Participants

Bill Plovanic - Canaccord Genuity

Calvin Chu - Morgan Stanley

Josh Jennings - Cowen

Suraj Kalia - Oppenheimer

Allen Gong - JPMorgan


Good afternoon, and welcome to TransMedics Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. We will be facilitating a question-and-answer session towards the end of today's call. As a reminder, this call is being recorded for replay process.

I would now like to turn the call over to Brian Johnston from the Gilmartin Group for a few introductory comments.

Brian Johnston

Thanks, operator. Earlier today, TransMedics released financial results for the quarter ended June 30, 2022. A copy of the press release is available on the company's Web site.

Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements.

All forward-looking statements, including, without limitation, are examination of operating trends, the potential commercial opportunity for our products, and our future financial expectations, which include expectations for growth in our organization, regulatory approvals, and reimbursement, and guidance and/or expectations for revenue, gross margins, and operating expenses in 2022 are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About TMDX

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on TMDX

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.